Hypoalbuminemia, a drop in blood albumin below the normal range of roughly 3.5 to 5.0 g/dL, is almost never a standalone diagnosis. It is a signal that something else has gone wrong: the liver is failing to produce enough albumin, the kidneys or gut are losing it, or severe inflammation is reshuffling how the body handles it. Treatment therefore depends entirely on identifying and addressing the underlying cause, though intravenous albumin infusions play a well-defined role in specific clinical scenarios, particularly advanced liver disease and septic shock.
What Albumin Actually Does
Albumin is the most abundant protein in blood plasma, making up about 60% of total plasma protein by mass. Its most critical job is maintaining oncotic pressure, the force that keeps fluid inside blood vessels rather than leaking into surrounding tissues.1Pedagogy and Psychology of Sport. Water, Proteins, and Volume Regulation: Molecular Mechanisms of Hydration and Oncotic Balance When albumin levels fall, that pressure drops, and fluid seeps into tissues. The result is edema: swollen ankles, a puffy face, or fluid accumulating in the abdomen.
Beyond holding fluid in the right compartment, albumin acts as a transport vehicle for hormones, fatty acids, and medications. It also functions as a significant circulating antioxidant, trapping free radicals and binding potentially harmful molecules.2PubMed. The antioxidant properties of serum albumin These roles explain why low albumin has ripple effects well beyond simple swelling. Drugs that normally hitch a ride on albumin circulate differently, wounds heal more slowly, and the body’s defenses against oxidative damage weaken.3PubMed Central. Antioxidant Properties of Albumin and Diseases Related to Obstetrics and Gynecology
Major Causes of Low Albumin
Hypoalbuminemia has four broad categories of causes, and patients often have more than one operating at the same time.
Reduced Production From Liver Disease
The liver is the sole manufacturer of albumin. In cirrhosis, scarred liver tissue loses the ability to ramp up albumin production after meals the way a healthy liver does. Research comparing cirrhosis patients with healthy controls found that after eating, healthy subjects increased their albumin production rate substantially, while patients with compensated cirrhosis showed no increase at all.4PubMed. Impairment of albumin and whole body postprandial protein synthesis in compensated liver cirrhosis As cirrhosis progresses, baseline production falls further, and albumin levels drop steadily. This is why serum albumin is one of the variables in scoring systems that gauge how sick a liver-disease patient is.
Urinary Losses in Kidney Disease
In nephrotic syndrome, damage to the kidney’s filtration barrier lets large proteins slip through into urine. Albumin, being the most abundant plasma protein, accounts for the bulk of those losses.5PubMed Central. Nephrotic Syndrome Complications – New and Old. Part 1. Patients can lose grams of albumin per day in their urine. The liver tries to compensate by producing more, but in severe cases it cannot keep up, and serum albumin plummets. The resulting edema in nephrotic syndrome can be dramatic, sometimes causing the face, legs, and abdomen to swell visibly within days.
Gastrointestinal and Nutritional Losses
Protein-losing enteropathy is a condition where the gut leaks protein, including albumin, into the intestinal lumen. This can happen with intestinal lymphangiectasia, inflammatory bowel disease, or other disorders that damage the gut lining. Management involves a high-protein diet, supplementation with fat-soluble vitamins, and in cases involving lymphatic abnormalities, a low-fat diet supplemented with medium-chain triglycerides, alongside treatment of the underlying disorder.6PubMed Central. Clinical practice. Protein-losing enteropathy in children. Severe malnutrition from any cause can also lead to hypoalbuminemia simply because the body lacks the raw materials to synthesize adequate protein.
Inflammation and Critical Illness
This is perhaps the most underappreciated cause. In severe infections, major surgery, trauma, or sepsis, systemic inflammation causes blood vessel walls to become leaky, a phenomenon called capillary leak syndrome. Albumin escapes from the bloodstream into surrounding tissues, and the liver simultaneously downshifts albumin production in favor of churning out acute-phase proteins used in the inflammatory response.7PubMed. Role of albumin in diseases associated with severe systemic inflammation: Pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis Capillary leak can have serious consequences: fluid pools in tissues while the vascular space becomes depleted, leading to poor organ perfusion.8PubMed Central. Capillary leak and endothelial permeability in critically ill patients: a current overview In this setting, a low albumin level reflects the severity of the illness more than a protein deficit per se.
Why Low Albumin Matters Before Surgery
Even outside the ICU, hypoalbuminemia is one of the strongest predictors of poor surgical outcomes. A large multi-specialty analysis found that patients with low preoperative albumin had roughly double the odds of dying after surgery, along with increased risks of cardiac arrest, stroke, and reoperation.9PubMed Central. The Association between Serum Albumin and Post-Operative Outcomes among Patients Undergoing Common Surgical Procedures: An Analysis of a Multi-Specialty Surgical Cohort from the National Surgical Quality Improvement Program (NSQIP) The pattern holds across different types of procedures. In one study of bladder cancer surgery, every 1 g/dL decrease in preoperative albumin roughly tripled the odds of death within 90 days.10PubMed Central. Preoperative Serum Albumin Is Associated With Mortality and Complications After Radical Cystectomy Research in vascular surgery shows a similar dose-response relationship: the lower the albumin, the worse the outcomes, with levels below about 2.8 g/dL carrying particularly high risk.11PubMed. Hypoalbuminemia Predicts Perioperative Morbidity and Mortality after Infrainguinal Lower Extremity Bypass for Critical Limb Ischemia
This does not necessarily mean that infusing albumin before an operation fixes the problem. Low albumin is often a marker of poor nutritional status, chronic disease, or hidden inflammation. Simply topping off the number without addressing why it is low is unlikely to change the trajectory. Whether preoperative albumin optimization through nutritional support actually improves outcomes is an area of ongoing study, and most surgeons treat hypoalbuminemia as a risk flag that triggers closer preoperative evaluation rather than a simple number to correct.
Albumin Infusion in Liver Disease
Cirrhosis is the clinical setting where intravenous albumin has the most established evidence base. Three specific situations stand out.
After Large-Volume Paracentesis
When patients with cirrhosis accumulate large amounts of fluid in their abdomen (ascites), the standard procedure is to drain it. Removing several liters at once can destabilize the circulatory system, a complication called post-paracentesis circulatory dysfunction. Albumin infusion during or after the procedure substantially reduces this risk. A meta-analysis of randomized trials found that albumin cut the odds of circulatory dysfunction by about 60% compared with alternative volume expanders like synthetic starches or saline, and also reduced mortality.12PubMed. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials This is now standard practice: albumin is infused (typically 6 to 8 grams per liter of fluid removed) whenever a large-volume tap is performed.13PubMed Central. Role of albumin in cirrhosis: from a hospitalist’s perspective
Spontaneous Bacterial Peritonitis
Spontaneous bacterial peritonitis (SBP) is a serious infection of ascitic fluid that carries a high risk of kidney failure and death. A landmark trial showed that adding albumin to antibiotic therapy cut the rate of kidney injury from about 33% to 10% and reduced in-hospital mortality from 29% to 10%.14PubMed. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis Subsequent research has refined this, suggesting that the benefit is concentrated in higher-risk patients, specifically those who already have elevated bilirubin or signs of kidney stress at the time of diagnosis. In high-risk SBP episodes, the number of patients you need to treat with albumin to prevent one death during hospitalization is roughly five to six.15Clinical Gastroenterology and Hepatology. Effects of Albumin Treatment in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis Based on Risk Stratification For lower-risk SBP episodes, the added benefit of albumin is less clear.16PubMed Central. Should albumin be used in all patients with spontaneous bacterial peritonitis?
Albumin in Sepsis and Critical Care
The use of albumin for fluid resuscitation in critically ill patients has a long and somewhat contentious history. The SAFE trial, a large randomized study comparing 4% albumin with normal saline in ICU patients, found no difference in 28-day mortality, ICU stay, or organ failure rates between the two groups.17PubMed. A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit That trial essentially established that albumin is safe for general resuscitation, but no better than cheap saline for the average ICU patient.
Sepsis is a different story, though the picture is nuanced. The ALBIOS trial, specifically studying sepsis patients, found that albumin improved blood pressure and reduced net fluid balance compared with crystalloid alone, but did not reduce mortality at 28 or 90 days overall.18PubMed. Albumin replacement in patients with severe sepsis or septic shock However, when researchers zoomed in on patients with septic shock specifically, something interesting emerged. A meta-analysis of trials in septic shock found that albumin significantly reduced 90-day mortality, with odds roughly 19% lower than crystalloid.19PubMed Central. Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials A more recent systematic review using both traditional and Bayesian statistical approaches confirmed an approximately 10% reduction in relative mortality risk with albumin-based resuscitation in septic shock, with a high probability that the benefit is real.20PubMed Central. Mortality effect of albumin fluid resuscitation in adults with septic shock: a systematic review and dual frequentist-bayesian meta-analysis of randomised trials
So the emerging picture is that for the general ICU population, albumin does not beat saline. For sepsis broadly, it is roughly equivalent. But for the sickest subset with septic shock, there appears to be a modest mortality benefit. A Cochrane review of colloids versus crystalloids in critically ill patients broadly concluded there is probably little or no difference in mortality between albumin and crystalloid across the general critical care population.21Cochrane Database of Systematic Reviews. Colloids versus crystalloids for fluid resuscitation in critically ill people The clinical challenge is figuring out which patients fall into that narrower group that might benefit.
Managing Edema in Nephrotic Syndrome
In nephrotic syndrome, the kidneys are dumping albumin into urine, so infusing it intravenously feels intuitively logical but comes with a catch: much of the infused albumin can quickly end up in the urine as well. The main clinical use is pairing albumin with a loop diuretic to break through resistant edema. In theory, temporarily raising the plasma albumin level helps the diuretic reach the kidney tubule more effectively and pulls fluid back into the vascular space where the kidney can excrete it.22PubMed Central. Albumin and Furosemide Combination for Management of Edema in Nephrotic Syndrome: A Review of Clinical Studies
A crossover trial in children with refractory edema from nephrotic syndrome found that combining albumin with furosemide roughly doubled urine output compared with furosemide alone and led to significantly greater weight loss over the treatment period.23PubMed. Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome But this was a small study, and the results have not been consistent across all trials. The combination is typically reserved for patients whose edema is not responding to diuretics alone, rather than used as a first-line strategy. The definitive treatment for nephrotic hypoalbuminemia remains controlling the underlying kidney disease, whether through immunosuppressive therapy, treating the triggering condition, or managing blood pressure and proteinuria.
Why IV Albumin Is Not a Nutritional Fix
One persistent misconception is that hypoalbuminemia caused by malnutrition should be treated by infusing albumin. This seems logical on the surface: the protein is low, so replace it. But randomized trials have shown that while IV albumin temporarily raises the serum level, it does not actually improve clinical outcomes in malnourished patients receiving nutritional support. The evidence that IV albumin benefits malnourished patients is weak and contradictory, and the therapy carries its own risks and considerable cost.24PubMed. Intravenous albumin and nutrition support: going for the quick fix The body breaks down infused albumin within a few weeks, so any bump in serum levels is transient unless the underlying production deficit is addressed.
For nutritionally driven hypoalbuminemia, the right approach is adequate protein and calorie intake, whether by mouth, tube feeding, or intravenous nutrition. Correcting the nutritional deficit allows the liver to resume making its own albumin at a sustainable rate. Chasing the serum number with expensive albumin infusions is treating the lab value, not the patient.
Risks of Albumin Infusion
Albumin is a blood-derived product, and while modern manufacturing has made viral transmission essentially a non-issue, the therapy is not without downsides. Recognized adverse effects include fluid overload (particularly in patients whose hearts or kidneys cannot handle the extra volume), hemodilution that can worsen anemia, allergic reactions, and in rare cases hypotension during infusion.25CHEST. Use of Intravenous Albumin: A Guideline From the International Collaboration for Transfusion Medicine Guidelines Pulmonary edema is a particular concern; concentrated albumin solutions pull fluid into the vascular space, and if the heart cannot pump that extra volume forward, fluid backs up into the lungs. In clinical trials of albumin in cirrhosis, serious adverse events including pulmonary edema have been numerically more frequent in albumin-treated groups.
There is also the question of cost. Human albumin is derived from pooled donor plasma, making it far more expensive than crystalloid solutions like saline. For indications where albumin has proven mortality or morbidity benefit, such as large-volume paracentesis in cirrhosis or high-risk SBP, the cost is justified. For indications where it performs equivalently to saline, the expense is difficult to defend.
How Concentrated Albumin Works Differently
Not all albumin solutions are the same. A 5% albumin solution has roughly the same oncotic pressure as blood and primarily replaces volume one-for-one. A 20% or 25% solution is hyper-oncotic: it generates enough osmotic pull to draw additional fluid from the tissues into the bloodstream, effectively expanding plasma volume by about twice the infused amount.26PubMed Central. Albumin 20% in surgical and critically ill patients; a comprehensive review This makes concentrated albumin useful when the goal is to mobilize excess tissue fluid, such as in patients with peripheral edema or ascites, but it also means the risk of circulatory overload is higher. Clinicians choose between formulations based on whether the patient needs volume expansion or fluid redistribution, and the distinction has real implications for how much total fluid ends up in the vascular space.
A Measurement Pitfall Worth Knowing About
There is a technical wrinkle in how albumin is measured that can mislead clinicians. The two common lab methods for measuring serum albumin, known by their chemical dyes (bromocresol green and bromocresol purple), do not always agree. The bromocresol green method tends to overestimate albumin, and the overestimation gets worse as albumin levels fall. In patients with severe hypoalbuminemia, the difference between the two methods can be nearly 10 g/L, which is clinically significant. The bias appears driven by the bromocresol green dye reacting with inflammatory proteins that accumulate when albumin is low.27Laboratory Medicine. Overestimation of Albumin Measured by Bromocresol Green vs Bromocresol Purple Method: Influence of Acute-Phase Globulins In practice, this means a critically ill patient with genuinely dangerously low albumin may appear to have a less concerning level on the lab report, depending on which assay the hospital uses. If treatment decisions hinge on the albumin level, knowing which method your lab employs matters.